VUB researcher Damya Laoui selected as Innovator under 35 Europe

Innovators Under 35 is an initiative of the Technology Review magazine from the Massachusetts Institute of Technology. Damya Laoui is a postdoctoral scientist at the lab Myeloid Cell Immunology (VUB-VIB). Her research is focused on the use of dendritic cells as a vaccin to combat cancer.

Relevant publications:

Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapies.

Keirsse J, Van Damme H, Van Ginderachter JA, Laoui D.

J Leukoc Biol. 2017 Aug;102(2):317-324. doi: 10.1189/jlb.4MR1116-466R. Epub 2017 Apr 7. Review.

The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity.

Laoui D, Keirsse J, Morias Y, Van Overmeire E, Geeraerts X, Elkrim Y, Kiss M, Bolli E, Lahmar Q, Sichien D, Serneels J, Scott CL, Boon L, De Baetselier P, Mazzone M, Guilliams M, Van Ginderachter JA.

Nat Commun. 2016 Dec 23;7:13720. doi: 10.1038/ncomms13720.